Tuesday, 29 September 2026Updated 13m ago
← Top stories
Legal● Neutral for Indian equities

'Carnage, Plain And Simple': Supreme Court Flags Rs 27,000 MRP On Rs 3,000 Cancer Drug

1 source · first seen 16:25 29 Sept · updated 16:25 29 Sept

The brief

Written from 1 report · check the source before you trade
  • The Supreme Court flagged a ₹27,000 MRP for a cancer drug costing ₹3,000
  • The court questioned the steep PTR-MRP gap, hospital pharmacy practices and taxpayer burden
  • Hospital pricing scrutiny may affect Indian hospitals and pharmaceutical companies

Tags on this story

Pick a tag to see all its stories
Supreme Court14 todayHospitals7 todayPharma and healthcare42 today

Linked by the tag Hospitals

27 stories this week
  1. 27 SeptFortis confident of clean chit from audit in Singh brothers’ disputeLegal · 1 source · Fortis expects a clean chit from the audit in the Singh brothers’ dispute
All Hospitals stories →

Read the reports

1 report · earliest 16:25
NDTV Profit'Carnage, Plain And Simple': Supreme Court Flags Rs 27,000 MRP On Rs 3,000 Cancer Drug16:25